Chemotherapy-Related Neurotoxicity
- PMID: 27443648
- DOI: 10.1007/s11910-016-0686-x
Chemotherapy-Related Neurotoxicity
Abstract
Chemotherapy may have detrimental effects on either the central or peripheral nervous system. Central nervous system neurotoxicity resulting from chemotherapy manifests as a wide range of clinical syndromes including acute, subacute, and chronic encephalopathies, posterior reversible encephalopathy, acute cerebellar dysfunction, chronic cognitive impairment, myelopathy, meningitis, and neurovascular syndromes. These clinical entities vary by causative agent, degree of severity, evolution, and timing of occurrence. In the peripheral nervous system, chemotherapy-induced peripheral neuropathy (CIPN) and myopathy are the two main complications of chemotherapy. CIPN is the most common complication, and the majority manifest as a dose-dependent length-dependent sensory axonopathy. In severe cases of CIPN, the dose of chemotherapy is reduced, the administration delayed, or the treatment discontinued. Few treatments are available for CIPN and based on meta-analysis, duloxetine is the preferred symptomatic treatment. Myopathy due to corticosteroid use is the most frequent cause of muscle disorders in patients with cancer.
Keywords: Chemobrain; Chemotherapy; Chemotherapy-induced peripheral neuropathy; Encephalopathy; Myopathy; Neurotoxicity.
Similar articles
-
Chemotherapy-induced peripheral neurotoxicity.Curr Opin Neurol. 2015 Oct;28(5):500-7. doi: 10.1097/WCO.0000000000000234. Curr Opin Neurol. 2015. PMID: 26197027 Review.
-
A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.Cancer. 2012 Apr 15;118(8 Suppl):2250-60. doi: 10.1002/cncr.27463. Cancer. 2012. PMID: 22488699 Review.
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Support Care Cancer. 2017 Jan;25(1):195-204. doi: 10.1007/s00520-016-3404-y. Epub 2016 Sep 9. Support Care Cancer. 2017. PMID: 27612466 Clinical Trial.
-
Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity.Curr Opin Neurol. 2019 Oct;32(5):676-683. doi: 10.1097/WCO.0000000000000724. Curr Opin Neurol. 2019. PMID: 31306214 Review.
-
Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.Support Care Cancer. 2020 Jun;28(6):2553-2562. doi: 10.1007/s00520-019-05063-x. Epub 2019 Sep 7. Support Care Cancer. 2020. PMID: 31494735 Free PMC article.
Cited by
-
Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer.JAMA Netw Open. 2022 Nov 1;5(11):e2239788. doi: 10.1001/jamanetworkopen.2022.39788. JAMA Netw Open. 2022. PMID: 36322088 Free PMC article.
-
Mechanisms of Chemotherapy-Induced Neurotoxicity.Front Pharmacol. 2022 Mar 28;13:750507. doi: 10.3389/fphar.2022.750507. eCollection 2022. Front Pharmacol. 2022. PMID: 35418856 Free PMC article. Review.
-
Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches.Front Mol Biosci. 2022 Jul 15;9:962889. doi: 10.3389/fmolb.2022.962889. eCollection 2022. Front Mol Biosci. 2022. PMID: 35911961 Free PMC article. No abstract available.
-
Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity.Mol Neurobiol. 2019 Aug;56(8):5626-5642. doi: 10.1007/s12035-019-1474-9. Epub 2019 Jan 18. Mol Neurobiol. 2019. PMID: 30659419
-
Effect of chemotherapy on effect-site concentration of propofol for loss of consciousness in patients with colorectal cancer.Korean J Anesthesiol. 2022 Apr;75(2):160-167. doi: 10.4097/kja.21327. Epub 2021 Sep 17. Korean J Anesthesiol. 2022. PMID: 34551470 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical